BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11868866)

  • 1. Lipoprotein (a): role in diabetes and its vascular complications.
    Mohan A; Srinivasan V; Deepa R; Mohan V
    J Assoc Physicians India; 2001 Nov; 49():1100-5. PubMed ID: 11868866
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
    Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M
    Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
    J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet adhesiveness in diabetes mellitus with and without vascular complications.
    Ramani A; Kumar S; Tyagi N
    J Assoc Physicians India; 1986 Nov; 34(11):792-3. PubMed ID: 3558304
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
    Koschinsky ML; Marcovina SM
    Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the system of hemostasis in the development of vascular lesions in diabetes mellitus].
    Lapotnikov VA; Moiseev SI
    Ter Arkh; 1988; 60(9):31-5. PubMed ID: 3217876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.
    Pappachan JM; Sebastian J; Bino BC; Jayaprakash K; Vijayakumar K; Sujathan P; Adinegara LA
    Postgrad Med J; 2008 Apr; 84(990):205-10. PubMed ID: 18424578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Framingham risk equations underestimate coronary heart disease risk in diabetes.
    Stevens RJ; Coleman RL; Holman RR
    Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
    [No Abstract]   [Full Text] [Related]  

  • 9. Does lipoprotein(a) predict risk in type 2 diabetes?
    Kostner KM
    Eur J Clin Invest; 2006 Feb; 36(2):67-8. PubMed ID: 16436086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipoprotein(a). Its relationship with atherosclerosis and diabetes].
    Martínez MT; Pérez F; Calvillán M; Gutiérrez-López MD; Serrano Ríos M
    Rev Clin Esp; 1994 May; 194(5):361-7. PubMed ID: 8059034
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular complications of diabetes.
    Lau DC; Shen GX
    Can J Diabetes; 2013 Oct; 37(5):279-81. PubMed ID: 24500552
    [No Abstract]   [Full Text] [Related]  

  • 12. [The immunological aspects of the development of diabetes mellitus and its complications].
    Kamaeva OI
    Ter Arkh; 1994; 66(10):14-7. PubMed ID: 7863435
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.
    Hamed SA; Amine NF; Galal GM; Helal SR; Tag El-Din LM; Shawky OA; Ahmed EA; Abdel Rahman MS
    J Stroke Cerebrovasc Dis; 2008; 17(2):86-94. PubMed ID: 18346651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between low-density lipoprotein particle size and insulin and diabetes mellitus.
    Arisaka O; Ichikawa G; Koyama S; Shimura N
    J Pediatr; 2009 Oct; 155(4):600. PubMed ID: 19773013
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the lipoprotein profile in children with insulin treated type 1 diabetes mellitus].
    Schottmann B; Bergmann S; Jaross W; Michaelis D
    Z Med Lab Diagn; 1989; 30(1):76-7. PubMed ID: 2655330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Markers of vascular inflammation in diabetes mellitus type 2 with hypertension and albuminuria].
    Gómez-Fernández P; Ruiz A; Conde MR; Campos R; Vargas JC; Almaraz M
    Nefrologia; 2004; 24(1):67-9. PubMed ID: 15083960
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I; Cetinarslan B; Cantürk Z
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological aspects of diabetic angiopathies pathogenesis].
    Galenok VA; Zhuk EA
    Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.